These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30897760)

  • 1. A Systematic Pan-Cancer Analysis of Genetic Heterogeneity Reveals Associations with Epigenetic Modifiers.
    de Matos MR; Posa I; Carvalho FS; Morais VA; Grosso AR; de Almeida SF
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30897760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
    Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
    Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome.
    El Khoury LY; Pan X; Hlady RA; Wagner RT; Shaikh S; Wang L; Humphreys MR; Castle EP; Stanton ML; Ho TH; Robertson KD
    Clin Epigenetics; 2023 Apr; 15(1):71. PubMed ID: 37120552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic heterogeneity in cancer.
    Guo M; Peng Y; Gao A; Du C; Herman JG
    Biomark Res; 2019; 7():23. PubMed ID: 31695915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining multiple layers of intratumor heterogeneity based on variations of perturbations in multi-omics profiling.
    Ai H; Song D; Wang X
    Comput Biol Med; 2023 Jun; 159():106964. PubMed ID: 37099972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
    Li L; Chen C; Wang X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.
    Hua X; Zhao W; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Zhu B; Wang M; Jones K; Hicks B; Song L; Sampson J; Wedge DC; Shi J; Landi MT
    Nat Commun; 2020 May; 11(1):2459. PubMed ID: 32424208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
    Dentro SC; Leshchiner I; Haase K; Tarabichi M; Wintersinger J; Deshwar AG; Yu K; Rubanova Y; Macintyre G; Demeulemeester J; Vázquez-García I; Kleinheinz K; Livitz DG; Malikic S; Donmez N; Sengupta S; Anur P; Jolly C; Cmero M; Rosebrock D; Schumacher SE; Fan Y; Fittall M; Drews RM; Yao X; Watkins TBK; Lee J; Schlesner M; Zhu H; Adams DJ; McGranahan N; Swanton C; Getz G; Boutros PC; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Martincorena I; Markowetz F; Mustonen V; Yuan K; Gerstung M; Spellman PT; Wang W; Morris QD; Wedge DC; Van Loo P;
    Cell; 2021 Apr; 184(8):2239-2254.e39. PubMed ID: 33831375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer analysis of intratumor heterogeneity associated with patient prognosis using multidimensional measures.
    Kikutake C; Yoshihara M; Sato T; Saito D; Suyama M
    Oncotarget; 2018 Dec; 9(102):37689-37699. PubMed ID: 30701024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
    Song D; Wang X
    J Transl Med; 2022 Apr; 20(1):150. PubMed ID: 35365157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumor heterogeneity: evolution through space and time.
    Swanton C
    Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-regional sequencing reveals intratumor heterogeneity and positive selection of somatic mtDNA mutations in hepatocellular carcinoma and colorectal cancer.
    Li X; Guo X; Li D; Du X; Yin C; Chen C; Fang W; Bian Z; Zhang J; Li B; Yang H; Xing J
    Int J Cancer; 2018 Sep; 143(5):1143-1152. PubMed ID: 29569724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach.
    Goto T; Hirotsu Y; Amemiya K; Mochizuki H; Omata M
    Cancers (Basel); 2018 Jun; 10(7):. PubMed ID: 29932159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.
    McBride M; Rida PC; Aneja R
    Mol Aspects Med; 2015 Nov; 45():3-13. PubMed ID: 26024970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumor heterogeneity: A new perspective on colorectal cancer research.
    Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
    Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.
    Andor N; Graham TA; Jansen M; Xia LC; Aktipis CA; Petritsch C; Ji HP; Maley CC
    Nat Med; 2016 Jan; 22(1):105-13. PubMed ID: 26618723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring intratumor heterogeneity by network entropy using RNA-seq data.
    Park Y; Lim S; Nam JW; Kim S
    Sci Rep; 2016 Nov; 6():37767. PubMed ID: 27883053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
    Zhang LL; Kan M; Zhang MM; Yu SS; Xie HJ; Gu ZH; Wang HN; Zhao SX; Zhou GB; Song HD; Zheng CX
    Int J Cancer; 2017 Jan; 140(1):103-108. PubMed ID: 27646734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer.
    Yun JW; Lee S; Ryu D; Park S; Park WY; Joung JG; Jeong J
    Transl Oncol; 2019 Jan; 12(1):43-48. PubMed ID: 30265975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SpliceHetero: An information theoretic approach for measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq.
    Kim M; Lee S; Lim S; Kim S
    PLoS One; 2019; 14(10):e0223520. PubMed ID: 31644551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.